Search

Your search keyword '"Ono, Chikako"' showing total 289 results

Search Constraints

Start Over You searched for: Author "Ono, Chikako" Remove constraint Author: "Ono, Chikako"
289 results on '"Ono, Chikako"'

Search Results

2. Establishment and clinical application of SARS-CoV-2 catch column

5. Intranasal immunization with an RBD-hemagglutinin fusion protein harnesses preexisting immunity to enhance antigen-specific responses

9. Preclinical study of a DNA vaccine targeting SARS-CoV-2

12. BCR, not TCR, repertoire diversity is associated with favorable COVID-19 prognosis.

13. SARS-CoV-2 infection triggers paracrine senescence and leads to a sustained senescence-associated inflammatory response

14. BCR, not TCR, repertoire diversity is associated with favorable COVID-19 prognosis

16. An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies

19. Vero cell-adapted SARS-CoV-2 strain shows increased viral growth through furin-mediated efficient spike cleavage

20. Characterization of a neutralizing antibody that recognizes a loop region adjacent to the receptor-binding interface of the SARS-CoV-2 spike receptor-binding domain

21. Combining machine learning and nanopore construction creates an artificial intelligence nanopore for coronavirus detection

23. JAK inhibition during the early phase of SARS-CoV-2 infection worsens kidney injury by suppressing endogenous antiviral activity in mice.

25. Electrolyzed hypochlorous acid water exhibits potent disinfectant activity against various viruses through irreversible protein aggregation

27. SARS-CoV-2 Neutralization Assay System using Pseudo-lentivirus

28. Neutralizing Antibody Response of the Wild-Type/Omicron BA.1 Bivalent Vaccine as the Second Booster Dose against Omicron BA.2 and BA.5

32. Upregulation of Robo4 expression by SMAD signaling suppresses vascular permeability and mortality in endotoxemia and COVID-19 models

33. Antibody feedback contributes to facilitating the development of Omicron-reactive memory B cells in SARS-CoV-2 mRNA vaccinees

34. Efficacy of the wild-type/Omicron BA.1 bivalent vaccine as the second booster dose against Omicron BA.2 and BA.5

35. Establishment and clinical application of SARS-CoV-2 catch column

36. SARS-CoV-2 disrupts respiratory vascular barriers by suppressing Claudin-5 expression

37. SARS-CoV-2 ORF8 is a viral cytokine regulating immune responses

38. Immune response induced in rodents by anti-CoVid19 plasmid DNA vaccine via pyro-drive jet injector inoculation

43. Secretory glycoprotein NS1 plays a crucial role in the particle formation of flaviviruses

45. SARS-CoV-2 disrupts respiratory vascular barriers by suppressing Claudin-5 expression

46. Secretory glycoprotein NS1 plays a crucial role in the particle formation of flaviviruses

47. Effectiveness of the third dose of BNT162b2 vaccine on neutralizing Omicron variant in the Japanese population

48. Age-Dependent Reduction in Neutralization against Alpha and Beta Variants of BNT162b2 SARS-CoV-2 Vaccine-Induced Immunity

49. Correlation of the Commercial Anti-SARS-CoV-2 Receptor Binding Domain Antibody Test with the Chemiluminescent Reduction Neutralizing Test and Possible Detection of Antibodies to Emerging Variants

Catalog

Books, media, physical & digital resources